Showing results (2261-2270 of 2,378) with videos related to

Sort By:
Pageof 238
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 18, 2024
Impact of facial nerve resection in parotid cancer abutting the facial nerve without preoperative paralysis: A multicentric propensity score-based analysisFlorian Chatelet, Sylvie Chevret, Nicolas Fakhry, et al.
Cell Metabolism|October 2, 2018
Mechanisms Preserving Insulin Action during High Dietary Fat IntakeAnne-Marie Lundsgaard, Jacob B Holm, Kim A Sjøberg, et al.
Molecular Genetics & Genomic Medicine|June 18, 2014
Novel IRF6 mutations in families with Van Der Woude syndrome and popliteal pterygium syndrome from sub-Saharan AfricaAzeez Butali, Peter A Mossey, Wasiu L Adeyemo, et al.
The Lancet. Healthy Longevity|March 3, 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trialJoël Guigay, Cécile Ortholan, Damien Vansteene, et al.
The New England Journal of Medicine|October 11, 2016
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckRobert L Ferris, George Blumenschein, Jerome Fayette, et al.
Nature|September 30, 2016
Atom-at-a-time laser resonance ionization spectroscopy of nobeliumMustapha Laatiaoui, Werner Lauth, Hartmut Backe, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 31, 2015
[Definition of botulinum toxin failure in neurogenic detrusor overactivity: Preliminary results of the DETOX survey]B Peyronnet, S Sanson, G Amarenco, et al.
The Journal of Urology|July 3, 2020
Pregnancy and Delivery in Women with Lower Urinary Tract Reconstruction: A National Multicenter Retrospective Study from the French-Speaking Neuro-Urology Study Group (GENULF) and the Neuro-Urology Committee of the French Association of UrologyE Bey, Q Manach, B Peyronnet, et al.
ESMO Open|May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)R Galot, C Le Tourneau, L Licitra, et al.
Pageof 238